Do PFAS bind serum proteins and persist in the body, with PFNA more persistent than PFHxA?

PFAS toxicokinetics are highly compound-specific: many circulate largely protein-bound, and clearance can range from weeks to multiple years. This matters for a 57-year-old because sustained exposure to slowly cleared PFAS can maintain serum concentrations long after a source is reduced or removed.

Distribution, persistence, and repeated exposure

• Serum protein binding is well established. PFOA and PFOS bind human serum albumin, and albumin reportedly carries >98% of PFAS with molecular weight <500 in native serum; only approximately 0.01–1.2% is unbound. Some PFAS also bind globulins.
• Human elimination varies markedly by chemical. Following contaminated-water exposure cessation, estimated serum half-lives were about 2.36–2.7 years for PFOA and 3.4–7.45 years for PFOS across cohorts. Reported values span roughly 44 days for PFBS to 5–7 years for PFHxS.
• For these slowly eliminated compounds, recurrent exposure can offset the decline expected after cessation, sustaining a higher retained body burden. The magnitude depends on the individual PFAS and exposure pattern.

Mechanistic explanation

• Albumin binding reduces the freely filtered fraction at the kidney. In addition, PFAS undergo transporter-mediated proximal-tubule reabsorption, involving OAT4, URAT1, and OATP2B1; efficient reabsorption contributes to prolonged serum half-lives.
• PFNA has low renal clearance, whereas PFHxA is predominantly eliminated in urine. Available estimates place PFNA at approximately 2.5–4.3 years, while an occupational cessation study estimated PFHxA’s geometric-mean half-life at 32 days (range 14–49 days), often becoming undetectable within 2–4 months.

Bottom line

• The evidence strongly supports protein binding, compound-dependent persistence, and higher retained burden with ongoing exposure. The specific PFNA–PFHxA comparison was not supported as labeled, despite available human and renal-clearance findings showing a pronounced years-versus-weeks-to-months contrast.